Corporate renovation in the trade war Oliver Blume sees “significantly more tense risk situation” for Volkswagen Volkswagen boss Oliver Blume has cleaned up for two and a half years. Now he wants to attack. But how should walking in the face of Trump’s customs policy, acute weakness in the China and the software problems? Go… Continue reading German Manager Magazin: Volkswagen CEO Oliver Blume Interview: “We are good in all disciplines” 004128
Tag: Possible_Terrorism_Warfare
Clean Technica: US EV Sales Rise As Tesla Sales Fall003969
Sign up for CleanTechnica’s Weekly Substack for Zach and Scott’s in-depth analyses and high level summaries, sign up for our daily newsletter, and/or follow us on Google News! Last Updated on: 13th April 2025, 03:12 pm EV sales in the United States rose 11 percent during the first quarter of 2025, to about 300,000 cars… Continue reading Clean Technica: US EV Sales Rise As Tesla Sales Fall003969
Google Is Helping Government Build an AI-Powered Border Surveillance System
Remember the guys who found a way to turn your personal information into cold hard cash? It brings us no pleasure to report that they’re now expanding into the border surveillance industry. Google, once a company that simply tracked your every move to serve targeted ads, is now a key player in the US Customs… Continue reading Google Is Helping Government Build an AI-Powered Border Surveillance System
Scientists Intrigued by Tree That Harnesses Electricity to Kill Its Enemies
For trees, lightning strikes are the great leveller. Stick your neck out by growing taller than the rest, and you risk getting zapped into oblivion. Hundreds of millions of trees suffer this fate every year. But the opposite appears to be the case for the towering tonka bean tree (Dipteryx oleifera), a native of the… Continue reading Scientists Intrigued by Tree That Harnesses Electricity to Kill Its Enemies
Commercial war: Tesla stops ordering luxury models in China
The customs dispute between China and the USA also affects Tesla. However, a different business area is likely to suffer more than the car division. ((Tesla,, Electric car))) Go to source
Homeland Security Email Tells a US Citizen to ‘Immediately’ Self-Deport
The United States Department of Homeland Security sent an email this week informing people living in the US on a temporary legal status that their “parole” has been revoked and instructed them to leave the country “immediately.” However, the email was also addressed to at least one US citizen, an immigration attorney from Massachusetts. And… Continue reading Homeland Security Email Tells a US Citizen to ‘Immediately’ Self-Deport
Week in Review: Jeff Bezos’ secret EV startup
Welcome back to Week in Review! We’ve got tons of cool stuff for your reading pleasure this week: Jeff Bezos backs EV startup Slate; a Meta whistleblower accuses the company of collusion; Waymo may use interior camera data; and much more. Let’s get to it! I want this: Slate, an EV startup, has the ambitious… Continue reading Week in Review: Jeff Bezos’ secret EV startup
Trump Trade: President says first deal on tariffs ‘close’ as China ups duties
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: CHINA RAISES TARIFFS: China raised its tariffs on U.S. goods to 125% from 84%. “If the U.S. continues to impose… Continue reading Trump Trade: President says first deal on tariffs ‘close’ as China ups duties
ICE Just Jailed One of America’s Top Young Age-Reversing Scientists
Image by Getty / Futursim Despite being backed by death-fearing billionaires, Donald Trump’s administration has detained — and seeks to deport — an acclaimed anti-aging researcher. As the New York Times reports, 30-year-old Kseniia Petrova, a Russian-born lab researcher at the Harvard Medical School, was detained at Boston’s Logan Airport upon returning from a trip to… Continue reading ICE Just Jailed One of America’s Top Young Age-Reversing Scientists
Clinical research results for Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan (sac-TMT) published in Nature Medicine, a top international medical journal
CHENGDU, China, April 12, 2025 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) today announced that results from a Phase 3 registrational clinical study evaluating the novel TROP2 antibody drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) for the treatment of adult patients with advanced triple-negative breast cancer (TNBC) and results from an early Phase I/II clinical… Continue reading Clinical research results for Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan (sac-TMT) published in Nature Medicine, a top international medical journal